Baker Bros. Advisors (GP) LLC, 10% Owner at Entrada Therapeutics, Inc. (TRDA), bought 40,947 shares at $6.42 ($261K) on 2022-06-06, disclosed to the SEC on 2022-06-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.82 | 279 | $2K | 0.6% |
| 2 | $5.82 | 2,364 | $14K | 5.3% |
| 3 | $6.35 | 921 | $6K | 2.2% |
| 4 | $6.35 | 7,815 | $50K | 19.0% |
| 5 | $6.42 | 3,118 | $20K | 7.7% |
| 6 | $6.42 | 26,450 |
| $170K |
| 65.1% |
| Total | $6.37 avg | 40,947 | $261K | 100% |
| Filing → |
| KOD | BUY | 2026-09-30 | $63.4M | — | Filing → |
| TRDA | BUY | 2025-11-12 | $2.6M | — | Filing → |
| CELC | BUY | 2025-09-10 | $19.1M | — | Filing → |